Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.
NLRP7 gene mutation
Oocyte donation
Recurrent hydatidiform mole
Trophoblastic disease
Journal
Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
28
04
2020
accepted:
16
06
2020
pubmed:
28
6
2020
medline:
28
5
2021
entrez:
28
6
2020
Statut:
ppublish
Résumé
Molar pregnancies are benign trophoblastic diseases associated with a risk of malignant transformation. If aetiology remains mostly unknown, the risk of recurrent molar pregnancy is around 1.5% after one molar pregnancy and around 25% after 2 molar pregnancies. In the later situation, genetic mutations have been described, increasing hugely this risk. In case of mutations, probability to obtain a normal pregnancy is estimated around 1.8%. We report the case of a Caucasian 30-year-old woman whose previous five spontaneous pregnancies had a negative outcome: a spontaneous miscarriage and then 4 complete hydatidiform moles. Genetic testing revealed that the patient carried two heterozygous mutations in the NLRP7 gene (c.2982-2A > G and Y318CfsX7). According to this, counselling was conducted to advocate for oocyte donation in order to obtain a normal pregnancy. This technique enabled a complication-free, singleton pregnancy that resulted in a healthy term live birth of a 2900 g female. Few months after delivery, the patient presented a new complete hydatidiform mole. Women presented with mutations in the NLRP7, KHDC3L or PADI6 genes are unlikely to obtain normal pregnancies, with a major risk of reproductive failure. In such a context, oocyte donation may be the best option. Only 4 normal pregnancies and deliveries have been published in this situation through this technique to our knowledge.
Identifiants
pubmed: 32592075
doi: 10.1007/s10815-020-01861-z
pii: 10.1007/s10815-020-01861-z
pmc: PMC7492304
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
NLRP7 protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2273-2277Références
Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):197-9
pubmed: 21439709
Ann Pathol. 2014 Dec;34(6):434-47
pubmed: 25499859
Annu Rev Pathol. 2017 Jan 24;12:449-485
pubmed: 28135560
Int J Fertil Steril. 2019 Jul;13(2):135-138
pubmed: 31037924
Hum Mutat. 2007 Jul;28(7):741
pubmed: 17579354
J Med Genet. 2009 Aug;46(8):569-75
pubmed: 19246479
Nature. 2002 Apr 4;416(6880):539-42
pubmed: 11932746
Hum Reprod Update. 2006 May-Jun;12(3):233-42
pubmed: 16540529
Reprod Biomed Online. 2015 Jul;31(1):120-4
pubmed: 25982095
Front Immunol. 2013 Aug 20;4:242
pubmed: 23970884
Nat Genet. 2006 Mar;38(3):300-2
pubmed: 16462743
World Health Organ Tech Rep Ser. 1983;692:7-81
pubmed: 6318459
Am J Hum Genet. 2011 Sep 9;89(3):451-8
pubmed: 21885028
Placenta. 2013 Jan;34(1):50-6
pubmed: 23201303
Eur J Cancer. 2015 Sep;51(13):1725-31
pubmed: 26092638
Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1270-7
pubmed: 1674641
J Assist Reprod Genet. 2018 Jun;35(6):967-973
pubmed: 29737470
J Reprod Med. 1998 Jan;43(1):87-97
pubmed: 9475155
Eur J Hum Genet. 2017 Aug;25(8):924-929
pubmed: 28561018
Clin Genet. 2007 Jan;71(1):25-34
pubmed: 17204043
Am J Obstet Gynecol. 2010 Dec;203(6):531-9
pubmed: 20728069
Lancet. 2011 Dec 3;378(9807):1974
pubmed: 22130487
Lancet. 2010 Aug 28;376(9742):717-29
pubmed: 20673583
J Biol Chem. 2005 Jun 10;280(23):21720-5
pubmed: 15817483
J Biol Chem. 2011 Dec 16;286(50):43313-23
pubmed: 22025618
Clin Exp Reprod Med. 2017 Mar;44(1):40-46
pubmed: 28428943
Eur J Hum Genet. 2018 Jul;26(7):1007-1013
pubmed: 29693651
Hum Reprod. 2015 Jan;30(1):159-69
pubmed: 25358348
Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):3-7
pubmed: 20171777